Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 6/20 | 0.56 |
| ▸ | CCNB1 | P14635 | 5/20 | 0.56 |
| ▸ | CCNE1 | P24864 | 5/20 | 0.56 |
| ▸ | CDK2 | P24941 | 5/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.40 |
| ▸ | AHCY | P23526 | 3/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.34 |
| ▸ | PI4KA | P42356 | 1/20 | 0.34 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.34 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.34 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5138537 | 0.83 | CDK1 (0.41) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL27635727 | 0.83 | CDK1 (0.58) | CDK1ADORA2AHSP90AA1ADORA1LMNA | |
| SCHEMBL7063138 | 0.78 | CDK1 (0.64) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL4123842 | 0.76 | ADORA2A (0.59) | ADORA2AAHCYADORA1PI4KAPI4K2B | |
| SCHEMBL29729351 | 0.76 | ADORA2A (0.59) | ADORA2AAHCYADORA1PI4KAPI4K2B | |
| SCHEMBL4864331 | 0.76 | ADORA2A (0.59) | ADORA2AAHCYADORA1PI4KAPI4K2B | |
| SCHEMBL27516653 | 0.75 | CCNE1 (0.70) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL27983442 | 0.75 | CDK1 (0.59) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL4361005 | 0.74 | ADORA1 (0.45) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL14677581 | 0.74 | CCNE1 (0.40) | CDK1CCNB1CCNE1CDK2ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2065365-A2 | Functional monomers for molecular recognition and catalysis | MIP Technologies AB (SE) | 2009-06-03 | — | — | EP | disclosed |
| EP-1927604-A1 | Functional monomers for molecular recognition and catalysis | MIP Technologies AB (SE) | 2008-06-04 | — | — | EP | disclosed |
| US-7332553-B2 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2008-02-19 | — | — | US | disclosed |
| US-20070106041-A1 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2007-05-10 | — | — | US | disclosed |
| US-7208557-B2 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2007-04-24 | — | — | US | disclosed |
| US-7208557-B2 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2007-04-24 | — | — | US | disclosed |
| US-20050159570-A1 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB, RESEARCH PARK IDEON (SE) | 2005-07-21 | — | — | US | disclosed |
| US-6870021-B2 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2005-03-22 | — | — | US | disclosed |
| US-20030166798-A1 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2003-09-04 | — | — | US | disclosed |
| EP-1250315-A1 | FUNCTIONAL MONOMERS FOR MOLECULAR RECOGNITION AND CATALYSIS | MIP Technologies AB (SE) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001055095-A1 | FUNCTIONAL MONOMERS FOR MOLECULAR RECOGNITION AND CATALYSIS | MIP TECHNOLOGIES AB (SE) | 2001-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070106041-A1 | Functional monomers for molecular recognition and catalysis | PCNA, MUS81, PNMT | CDK1 2842/4885CCNB1 2067/4885CCNE1 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.